Q6GGY1 (DYR_STAAR) Staphylococcus aureus (strain MRSA252)
Dihydrofolate reductase UniProtKBAFDB90v4InterProInteractive Modelling
159 aa; Sequence (Fasta) ;
13 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
51 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of dihydrofolate reductase from Staphylococcus aureus MW2 bound to NADP and p218 | monomer | 1×NAP; 1×MMV; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase with NADP(H) and empty folate pocket | monomer | 1×NAP; 2×GOL; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with benzyl-dihydropthalazine inhibitor and NADP(… | monomer | 1×NAP; 1×OWP; 2×GOL; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with propyl-DAP isobutenyl-dihydrophthalazine inh… | monomer | 1×0U5; 1×NAP; 1×GOL; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with ethyl-DAP isobutenyl-dihydrophthalazine inhi… | monomer | 1×NAP; 1×0U6; 1×GOL; | ||||
Assess | ||||||
Wild-type Staphylococcus aureus DHFR in complex with trimethoprim | monomer | 1×EDO; 1×TOP; | ||||
Assess | ||||||
Wild-type Staphylococcus aureus DHFR in complex with NADPH and trimethoprim | monomer | 1×TOP; 1×NDP; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with cyclopropyl-dimethyoxydihydropthalazine inhi… | monomer | 1×R0Y; 1×OWM; 1×GOL; 1×NAP; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with para-tolyl-dihydropthalazine inhibitor and N… | monomer | 1×NAP; 1×OWS; 2×GOL; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with para-methoxyphenyl-dimethyoxydihydropthalazi… | monomer | 2×GOL; 1×OWG; 1×NAP; | ||||
Assess | ||||||
S. aureus dihydrofolate reductase co-crystallized with 1-ethylpropyl-dihydropthalazine inhibitor an… | monomer | 1×NAP; 1×OWV; 2×GOL; | ||||
Assess | ||||||
S. aureus dihydrofoate reductase co-crystallized with 3,5-dimethylphenyl-dihydropthalazine inhibito… | monomer | 1×OWJ; 1×NAP; 2×GOL; | ||||
Assess | ||||||
Staph. aureus DHFR complexed with NADPH and AR-101 | monomer | 1×NDP; 1×XCF; | ||||
Assess | ||||||
Staph. aureus DHFR complexed with NADPH and AR-102 | monomer | 1×NDP; 1×XCF; | ||||
Assess | ||||||
S. aureus DHFR complexed with NADPH and iclaprim | monomer | 1×NDP; 1×XCF; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×NAP; 1×Q11; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate reductase in complex with NADPH and UCP1232 | monomer | 1×O71; 1×XNP; 1×NAP; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×NAP; 1×Q12; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×NAP; 1×Q19; | ||||
Assess | ||||||
Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2… | monomer | 1×NAP; 1×1VM; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×NAP; 1×Q26; | ||||
Assess | ||||||
Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2… | monomer | 1×NAP; 1×1DN; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×M23; 1×NAP; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×Q20; 1×NAP; | ||||
Assess | ||||||
Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2… | monomer | 1×NAP; 1×1VN; | ||||
Assess | ||||||
S. aureus Dihydrofolate Reductase complexed with novel 7-aryl-2,4-diaminoquinazolines | monomer | 1×Q27; 1×NAP; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with beta-NADPH, cyclic alpha-NADPH anomer … | monomer | 1×U06; 1×XNP; 1×NAP; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with cyclized alpha-NADPH anomer and 3'-(3-… | monomer | 1×XNP; 1×U75; 1×GOL; | ||||
Assess | ||||||
Staphylococcus aureus F98Y Dihydrofolate Reductase mutant complexed with beta-NADPH and 3'-(3-(2,4-… | monomer | 1×NAP; 1×U06; 1×GOL; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate reductase in complex with NADPH and Methotrexate | monomer | 1×MTX; 1×NAP; 1×GOL; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with beta-NADPH and UCP1191 | monomer | 1×UC9; 1×NAP; | ||||
Assess | ||||||
Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents: 7-(Benzimidazol-1-yl)-2… | monomer | 1×1VO; 1×NAP; | ||||
Assess | ||||||
Staphylococcus aureus H30N, F98Y Dihydrofolate Reductase mutant complexed with beta-NADPH and 3'-(3… | monomer | 1×NAP; 1×U06; 1×GOL; | ||||
Assess | ||||||
S. aureus F98Y DHFR complexed with TMP | monomer | 1×NAP; 1×TOP; | ||||
Assess | ||||||
F98Y TMP-resistant Dihydrofolate Reductase from Staphylococcus aureus with inhibitor RAB1 | monomer | 1×RAR; 1×NAP; 1×GOL; | ||||
Assess | ||||||
Wild Type Dihydrofolate Reductase from Staphylococcus aureus with inhibitor RAB1 | monomer | 1×RAR; 1×NAP; 1×GOL; | ||||
Assess | ||||||
S. aureus DHFR complexed with NADPH and folate | monomer | 1×NDP; 1×DHF; | ||||
Assess | ||||||
S. aureus DHFR complexed with NADPH and TMP | monomer | 1×NDP; 1×TOP; | ||||
Assess | ||||||
Crystal Structure of Staph. aureus DHFR complexed with NADPH and AR-101 | monomer | 1×NDP; 1×XCF; | ||||
Assess | ||||||
R-27 in Complex with S. aureus DHFR and tricyclic-NADPH (tNADPH) | monomer | 1×XNP; 1×06U; 1×ACT; | ||||
Assess | ||||||
R-27 In Complex with S. aureus DHFR and alpha-NADPH - Remediated for comparison with tNADPH | monomer | 1×NDW; 1×06U; 1×ACT; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and 6-ETHYL-5-[(3R)-3-[2-METHOXY… | monomer | 1×GOL; 1×G8J; 1×XNP; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with beta-NADPH, cyclic alpha-NADPH anomer … | monomer | 1×GOL; 1×U06; 1×XNP; 1×NAP; | ||||
Assess | ||||||
Staph. aureus DHFR F98Y complexed with AR-102 | monomer | 1×NAP; 1×XCF; | ||||
Assess | ||||||
Staphylococcus aureus F98Y DHFR complexed with iclaprim | monomer | 1×NAP; 1×I2H; | ||||
Assess | ||||||
Staphylococcus aureus H30N, F98Y Dihydrofolate Reductase complexed with NADPH and 2,4-diamino-5-(3-… | monomer | 1×N22; 1×NDP; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and 6-ETHYL-5-[(3S)-3-[3-METHOXY… | monomer | 1×NDP; 1×06W; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and 6-ETHYL-5-[(3R)-3-[3-METHOXY… | monomer | 1×06U; 1×ACT; 1×NDP; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and 6-ethyl-5-(3-(4-methoxybiphe… | monomer | 1×NDP; 1×5DR; | ||||
Assess | ||||||
Staphylococcus aureus V31Y, F92I mutant dihydrofolate reductase complexed with NADPH and 5-[(3S)-3-… | monomer | 1×NDP; 1×52V; | ||||
Assess | ||||||
Staphylococcus aureus Dihydrofolate Reductase complexed with NADPH and 6-ETHYL-5-[(3R)-3-[3-METHOXY… | monomer | 1×06U; 1×ACT; 1×NDP; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
6e4e.1.A | monomer | 0.91 | 1×NAP; 1×MMV; | 100.00 | ||
Assess |